Key result
Microalbuminuria is a strong, independent predictor of cardiovascular events in hypertensive patients, and its reduction under treatment parallels changes in cardiovascular risk.
Why the study?
Does the assessment and reduction of microalbuminuria improve cardiovascular risk evaluation and outcomes in hypertensive patients?
Does the assessment and reduction of microalbuminuria improve cardiovascular risk evaluation and outcomes in hypertensive patients?
Routine assessment of microalbuminuria is a valuable, low-cost tool for identifying high cardiovascular risk and monitoring treatment efficacy in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
May aid CV risk stratification in hypertension; leaves open whether reducing albuminuria improves outcomes.
Pontremoli et al. (2006) conducted a review in Hypertension. Microalbuminuria was evaluated on Cardiovascular morbidity and mortality. Microalbuminuria is a strong, independent predictor of cardiovascular events in hypertensive patients, and its reduction under treatment parallels changes in cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: